{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Nigella sativa", "cardiometabolic", "diabetes mellitus", "glycemic homeostasis", "lipid profile", "meta-analysis", "prediabetes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36034891", "DateRevised": {"Year": "2022", "Month": "08", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "11"}], "Language": ["eng"], "ELocationID": ["977756", "10.3389/fnut.2022.977756"], "Journal": {"ISSN": "2296-861X", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in nutrition", "ISOAbbreviation": "Front Nutr"}, "ArticleTitle": "<i>Nigella sativa</i> supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.", "Pagination": {"StartPage": "977756", "MedlinePgn": "977756"}, "Abstract": {"AbstractText": ["<i>Nigella sativa (N. sativa)</i> from the family <i>Ranunculaceae</i> has medicinal properties. Previous studies have reported promising findings showing that <i>N. sativa</i> may benefit cardiometabolic health; however, current evidence on its cardiometabolic effects on those with prediabetes and type 2 diabetes mellitus (T2DM) is still unclear. Hence, we conducted a systematic review and meta-analysis to assess the efficacy of <i>N. sativa</i> on cardiometabolic parameters in population with prediabetes and T2DM.", "PubMed/Medline, ISI Web of Science, Scopus, and Cochrane library were systematically searched up to June 20, 2022. Meta-analyses using random-effects models were used.", "Eleven randomized controlled trials (RCTs) were included in the meta-analysis. <i>N. sativa</i> intervention resulted in significant changes in fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), c-reactive protein (CRP), and malondialdehyde (MDA), without overall changes in glucose levels after oral glucose tolerance test (OGTT), fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), triglyceride, high-density lipoprotein cholesterol (HDL-C), and body mass index (BMI) when compared with the control group. In subgroup analyses, <i>N. sativa</i> supplementation enhanced serum levels of HDL-C in subjects with baseline HDL-C lower than 40 mg/dL. Furthermore, HOMA-IR and BMI values decreased in the <i>N. sativa</i>-supplemented group compared with the control group, when the length of follow-up was more than 8 weeks and the dose was more than 1 g/day for <i>N. sativa</i> supplementation, respectively.", "Our findings indicate that <i>N. sativa</i> supplementation may effectively improve cardiometabolic profiles in individuals with prediabetes and T2DM."], "CopyrightInformation": "Copyright \u00a9 2022 Saadati, Naseri, Asbaghi, Abhari, Zhang, Li and Gan."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, VIC, Australia."}], "LastName": "Saadati", "ForeName": "Saeede", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Naseri", "ForeName": "Kaveh", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Asbaghi", "ForeName": "Omid", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Abhari", "ForeName": "Khadijeh", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Agriculture and Food, Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Parkville, VIC, Australia."}], "LastName": "Zhang", "ForeName": "Pangzhen", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, China."}], "LastName": "Li", "ForeName": "Hua-Bin", "Initials": "HB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Plants and Human Health, Institute of Urban Agriculture, National Agricultural Science and Technology Center, Chinese Academy of Agricultural Sciences, Chengdu, China."}], "LastName": "Gan", "ForeName": "Ren-You", "Initials": "RY"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Nutr", "NlmUniqueID": "101642264", "ISSNLinking": "2296-861X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. . Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. (2017) 390:1151\u2013210. 10.1016/S0140-6736(17)32152-9", "ArticleIdList": ["10.1016/S0140-6736(17)32152-9", "PMC5605883", "28919116"]}, {"Citation": "Afroz A, Alramadan MJ, Hossain MN, Romero L, Alam K, Magliano DJ, et al. . Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review. BMC Health Serv Res. (2018) 18:972. 10.1186/s12913-018-3772-8", "ArticleIdList": ["10.1186/s12913-018-3772-8", "PMC6296053", "30558591"]}, {"Citation": "Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. (2019) 157:107843. 10.1016/j.diabres.2019.107843", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. . IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. (2017) 128:40\u201350. 10.1016/j.diabres.2017.03.024", "ArticleIdList": ["10.1016/j.diabres.2017.03.024", "28437734"]}, {"Citation": "Cho NH, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, et al. . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for (2045). Diabetes Res Clin Pract. (2018) 138:271\u201381. 10.1016/j.diabres.2018.02.023", "ArticleIdList": ["10.1016/j.diabres.2018.02.023", "29496507"]}, {"Citation": "Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics. (2004) 22:149\u201364. 10.2165/00019053-200422030-00002", "ArticleIdList": ["10.2165/00019053-200422030-00002", "14871163"]}, {"Citation": "Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Cardiovasc. Diabetol. Clin. Metab. Inflam. Facets. (2008) 45:1\u201316. 10.1159/000115118", "ArticleIdList": ["10.1159/000115118", "18230953"]}, {"Citation": "Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. (2013) 19:5695\u2013703. 10.2174/1381612811319320005", "ArticleIdList": ["10.2174/1381612811319320005", "23448484"]}, {"Citation": "Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care. (2007) 30:263\u20139. 10.2337/dc06-1612", "ArticleIdList": ["10.2337/dc06-1612", "17259492"]}, {"Citation": "Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. (2015) 6:1246\u201358. 10.4239/wjd.v6.i13.1246", "ArticleIdList": ["10.4239/wjd.v6.i13.1246", "PMC4600176", "26468341"]}, {"Citation": "Hossain MA, Pervin R. Current antidiabetic drugs: review of their efficacy and safety. Nutr Therap Interv Diabetes Metab Syndrome. (2018) 455\u201373. 10.1016/B978-0-12-812019-4.00034-9", "ArticleIdList": ["10.1016/B978-0-12-812019-4.00034-9"]}, {"Citation": "Coppell KJ, Kataoka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment\u2013Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial. BMJ. (2010) 341:c3337. 10.1136/bmj.c3337", "ArticleIdList": ["10.1136/bmj.c3337", "PMC2907481", "20647285"]}, {"Citation": "Xie W, Zhao Y, Zhang Y. Traditional chinese medicines in treatment of patients with type 2 diabetes mellitus. Evid Based Complement Alternat Med. (2011) 2011:726723. 10.1155/2011/726723", "ArticleIdList": ["10.1155/2011/726723", "PMC3092648", "21584252"]}, {"Citation": "Al-Naqeep G, Al-Zubairi AS, Ismail M, Amom ZH, Esa NM. Antiatherogenic potential of Nigella sativa seeds and oil in diet-induced hypercholesterolemia in rabbits. Evid Based Complement Alternat Med. (2011) 2011:213628. 10.1093/ecam/neq071", "ArticleIdList": ["10.1093/ecam/neq071", "PMC3136238", "21792359"]}, {"Citation": "Ermumcu MSK, Sanlier N. Black cumin (Nigella sativa) and its active component of thymoquinone: effects on health. Food Health. (2017) 3:170\u201383. 10.3153/JFHS17020", "ArticleIdList": ["10.3153/JFHS17020"]}, {"Citation": "Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. J Pharmacopunct. (2017) 20:179\u201393. 10.3831/KPI.2017.20.021", "ArticleIdList": ["10.3831/KPI.2017.20.021", "PMC5633670", "30087794"]}, {"Citation": "Darand M, Darabi Z, Yari Z, Saadati S, Hedayati M, Khoncheh A, et al. . Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: results from a randomized, double-blind, placebo-controlled, clinical trial. Complement Ther Med. (2019) 44:204\u20139. 10.1016/j.ctim.2019.04.014", "ArticleIdList": ["10.1016/j.ctim.2019.04.014", "31126557"]}, {"Citation": "Hamdan A, Haji Idrus R, Mokhtar MH. Effects of Nigella sativa on type-2 diabetes mellitus: a systematic review. Int J Environ Res Public Health. (2019) 16:911. 10.3390/ijerph16244911", "ArticleIdList": ["10.3390/ijerph16244911", "PMC6950756", "31817324"]}, {"Citation": "Jangjo-Borazjani S, Dastgheib M, Kiyamarsi E, Jamshidi R, Rahmati-Ahmadabad S, Helalizadeh M, et al. . Effects of resistance training and Nigella sativa on type 2 diabetes: implications for metabolic markers, low-grade inflammation and liver enzyme production. Arch Physiol Biochem. (2021) 21:1\u20139. 10.1080/13813455.2021.1886117", "ArticleIdList": ["10.1080/13813455.2021.1886117", "33612031"]}, {"Citation": "Mostafa TM, Hegazy SK, Elnaidany SS, Shehabeldin WA, Sawan ES. Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: a comparative study of Nigella sativa versus both lifestyle modification and metformin. J Diabetes Complications. (2021) 35:107947. 10.1016/j.jdiacomp.2021.107947", "ArticleIdList": ["10.1016/j.jdiacomp.2021.107947", "34006388"]}, {"Citation": "Rahmani A, Niknafs B, Naseri M, Nouri M, Tarighat-Esfanjani A. Effect of Nigella sativa oil on oxidative stress, inflammatory, and glycemic control indices in diabetic hemodialysis patients: a randomized double-blind, controlled trial. Evid Based Complement Alternat Med. (2022) 2022:2753294. 10.1155/2022/2753294", "ArticleIdList": ["10.1155/2022/2753294", "PMC9033343", "35463059"]}, {"Citation": "Abdelrazek HMA, Kilany OE, Muhammad MAA, Tag HM, Abdelazim AM. Black seed thymoquinone improved insulin secretion, hepatic glycogen storage, and oxidative stress in streptozotocin-induced diabetic male wistar rats. Oxid Med Cell Longev. (2018) 2018:8104165. 10.1155/2018/8104165", "ArticleIdList": ["10.1155/2018/8104165", "PMC5857299", "29686746"]}, {"Citation": "Saxena S, Pandey PT, Kumar V, Saxena JK. Antidyslipidemic and anti-oxidant activities of Nigella sativa seeds extract in hyperlipidemic rats. Int J Pharmaceut Sci Res. (2020) 25:4321\u20138. 10.13040/IJPSR.0975-8232.11(9).4321-28", "ArticleIdList": ["10.13040/IJPSR.0975-8232.11(9).4321-28"]}, {"Citation": "Hadi V, Kheirouri S, Alizadeh M, Khabbazi A, Hosseini H. Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Avicenna J Phytomed. (2016) 6:34\u201343.", "ArticleIdList": ["PMC4884216", "27247920"]}, {"Citation": "Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. (2009) 6:e1000097. 10.1371/journal.pmed.1000097", "ArticleIdList": ["10.1371/journal.pmed.1000097", "PMC2707599", "19621072"]}, {"Citation": "Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. (2011) 343:d5928. 10.1136/bmj.d5928", "ArticleIdList": ["10.1136/bmj.d5928", "PMC3196245", "22008217"]}, {"Citation": "Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. . Grading quality of evidence and strength of recommendations. BMJ. (2004) 328:1490. 10.1136/bmj.328.7454.1490", "ArticleIdList": ["10.1136/bmj.328.7454.1490", "PMC428525", "15205295"]}, {"Citation": "Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. (2005) 5:13. 10.1186/1471-2288-5-13", "ArticleIdList": ["10.1186/1471-2288-5-13", "PMC1097734", "15840177"]}, {"Citation": "Naseri K, Saadati S, Sadeghi A, Asbaghi O, Ghaemi F, Zafarani F, et al. . The efficacy of ginseng (panax) on human prediabetes and type 2 diabetes mellitus: a systematic review and meta-analysis. Nutrients. (2022) 14:2401. 10.3390/nu14122401", "ArticleIdList": ["10.3390/nu14122401", "PMC9227417", "35745129"]}, {"Citation": "Naseri K, Saadati S, Yari Z, Asbaghi O, Hezaveh ZS, Mafi D, et al. . Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Pharmacol Res. (2022) 182:106288. 10.1016/j.phrs.2022.106288", "ArticleIdList": ["10.1016/j.phrs.2022.106288", "35680009"]}, {"Citation": "Memon AR, Shah SS, Memon AR, Naqvi SHR. Effect of combination of Nigella sativa and Trigonella foenum-graecum with glibenclamide on serum triglyceride, HDL and creatinine levels in type-2 diabetes mellitus patients. Pak J Pharmacol. (2012) 29:1\u20136. Available online at: https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.1039.5365&rep=rep1&type=pdf"}, {"Citation": "Rao AS, Hegde S, Pacioretty LM, DeBenedetto J, Babish JG. Nigella sativa and trigonella foenum-graecum supplemented chapatis safely improve HbA1c, body weight, waist circumference, blood lipids, and fatty liver in overweight and diabetic subjects: a twelve-week safety and efficacy study. J Med Food. (2020) 23:905\u201319. 10.1089/jmf.2020.0075", "ArticleIdList": ["10.1089/jmf.2020.0075", "PMC7478223", "32758056"]}, {"Citation": "Shari FH, Ramadhan HH, Mohammed RN, Al Bahadily DC. Hypolipidemic and antioxidant effects of fenugreek-Nigella sativa combination on diabetic patients in Iraq. Syst Rev Pharm. (2020) 11:911\u201315."}, {"Citation": "Badar A, Kaatabi H, Bamosa A, Al-Elq A, Abou-Hozaifa B, Lebda F, et al. . Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial. Ann Saudi Med. (2017) 37:56\u201363. 10.5144/0256-4947.2017.56", "ArticleIdList": ["10.5144/0256-4947.2017.56", "PMC6148980", "28151458"]}, {"Citation": "Bamosa A, Kaatabi H, Badar A, Al-Khadra A, Al Elq A, Abou-Hozaifa B, et al. . Nigella sativa: a potential natural protective agent against cardiac dysfunction in patients with type 2 diabetes mellitus. J Family Community Med. (2015) 22:88\u201395. 10.4103/2230-8229.155380", "ArticleIdList": ["10.4103/2230-8229.155380", "PMC4415133", "25983604"]}, {"Citation": "Bilal A, Masud T, Uppal AM, Naveed AK. Effects of Nigella sativa oil on some blood parameters in type 2 diabetes mellitus patients. Asian J Chem. (2009) 21:5373. Available online at: https://www.cabdirect.org/cabdirect/abstract/20093257730", "ArticleIdList": ["0"]}, {"Citation": "Hadi S, Daryabeygi-Khotbehsara R, Mirmiran P, McVicar J, Hadi V, Soleimani D, et al. . Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res. (2021) 35:3747\u201355. 10.1002/ptr.6990", "ArticleIdList": ["10.1002/ptr.6990", "34142392"]}, {"Citation": "Bamosa AO, Kaatabi H, Lebdaa FM, Elq AM, Al-Sultanb A. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol. (2010) 54:344\u201354.", "ArticleIdList": ["21675032"]}, {"Citation": "Kaatabi H, Bamosa AO, Lebda FM, Al Elq AH, Al-Sultan AI. Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients. J Family Community Med. (2012) 19:155\u201361. 10.4103/2230-8229.102311", "ArticleIdList": ["10.4103/2230-8229.102311", "PMC3515953", "23230380"]}, {"Citation": "Najmi A, Nasiruddin M, Khan R, Haque SF. Therapeutic effect of Nigella sativa in patients of poor glycemic control. Asian J Pharm Clin Res. (2012) 5:224\u20138. Available online at: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-00908800/full", "ArticleIdList": ["10.1002/central/CN-00908800/full"]}, {"Citation": "Hosseini M, Mirkarimi S, Amini M, Mohtashami R, Kianbakht S, Fallah HH. Effects of Nigella sativa L. Seed Oil in Type II Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. (2013).", "ArticleIdList": ["23436437"]}, {"Citation": "Kaatabi H, Bamosa AO, Badar A, Al-Elq A, Abou-Hozaifa B, Lebda F, et al. . Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PLoS ONE. (2015) 10, e0113486. 10.1371/journal.pone.0113486", "ArticleIdList": ["10.1371/journal.pone.0113486", "PMC4338020", "25706772"]}, {"Citation": "Heshmati J, Namazi N, Memarzadeh M-R, Taghizadeh M, Kolahdooz F. Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Food Res Int. (2015) 70:87\u201393. 10.1016/j.foodres.2015.01.030", "ArticleIdList": ["10.1016/j.foodres.2015.01.030"]}, {"Citation": "Ansari ZM, Nasiruddin M, Khan RA, Haque SF. Protective role of Nigella sativa in diabetic nephropathy: a randomized clinical trial. Saudi J Kidney Dis Transpl. (2017) 28:9\u201314. 10.4103/1319-2442.198093", "ArticleIdList": ["10.4103/1319-2442.198093", "28098097"]}, {"Citation": "Hadi S, Mirmiran P, Daryabeygi-Khotbesara R, Hadi V. Effect of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress among people with type 2 diabetes mellitus: a randomized, double-blind, placebo controlled trial. Prog Nutr. (2018) 20:127\u201333. Available online at: http://eprints.mums.ac.ir/id/eprint/26375"}, {"Citation": "Kooshki A, Tofighiyan T, Rastgoo N, Rakhshani MH, Miri M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytother Res. (2020) 34:2706\u201311. 10.1002/ptr.6707", "ArticleIdList": ["10.1002/ptr.6707", "32510754"]}, {"Citation": "Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. (1997) 315:629\u201334. 10.1136/bmj.315.7109.629", "ArticleIdList": ["10.1136/bmj.315.7109.629", "PMC2127453", "9310563"]}, {"Citation": "Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. (1994) 50:1088\u2013101. 10.2307/2533446", "ArticleIdList": ["10.2307/2533446", "7786990"]}, {"Citation": "Meng J-M, Cao S-Y, Wei X-L, Gan R-Y, Wang Y-F, Cai S-X, et al. . Effects and mechanisms of tea for the prevention and management of diabetes mellitus and diabetic complications: an updated review. Antioxidants. (2019) 8:170. 10.3390/antiox8060170", "ArticleIdList": ["10.3390/antiox8060170", "PMC6617012", "31185622"]}, {"Citation": "Shang A, Liu H-Y, Luo M, Xia Y, Yang X, Li H-Y, et al. . Sweet tea (Lithocarpus polystachyus rehd) as a new natural source of bioactive dihydrochalcones with multiple health benefits. Crit Rev Food Sci Nutr. (2022) 62:917\u201334. 10.1080/10408398.2020.1830363", "ArticleIdList": ["10.1080/10408398.2020.1830363", "33030031"]}, {"Citation": "Gandhi GR, Vasconcelos ABS, Wu D-T, Li H-B, Antony PJ, et al. . Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: a systematic review of in vitro and in vivo studies. Nutrients. (2020) 12:2907. 10.3390/nu12102907", "ArticleIdList": ["10.3390/nu12102907", "PMC7598193", "32977511"]}, {"Citation": "Liu Y, Kong KW, Wu D-T, Liu H-Y, Li H-B, Zhang J-R, et al. . Pomegranate peel-derived punicalagin: ultrasonic-assisted extraction, purification, and its \u03b1-glucosidase inhibitory mechanism. Food Chem. (2022) 374:131635. 10.1016/j.foodchem.2021.131635", "ArticleIdList": ["10.1016/j.foodchem.2021.131635", "34823934"]}, {"Citation": "Li B-Y, Xu X-Y, Gan R-Y, Sun Q-C, Meng J-M, Shang A, et al. . Targeting gut microbiota for the prevention and management of diabetes mellitus by dietary natural products. Foods. (2019) 8:440. 10.3390/foods8100440", "ArticleIdList": ["10.3390/foods8100440", "PMC6835620", "31557941"]}, {"Citation": "Alasalvar C, Chang SK, Bolling B, Oh WY, Shahidi F. Specialty seeds: nutrients, bioactives, bioavailability, and health benefits: a comprehensive review. Compr Rev Food Sci Food Safety. (2021) 20:2382\u2013427. 10.1111/1541-4337.12730", "ArticleIdList": ["10.1111/1541-4337.12730", "33719194"]}, {"Citation": "Heshmati J, Namazi N. Effects of black seed (Nigella sativa) on metabolic parameters in diabetes mellitus: a systematic review. Complement Ther Med. (2015) 23:275\u201382. 10.1016/j.ctim.2015.01.013", "ArticleIdList": ["10.1016/j.ctim.2015.01.013", "25847566"]}, {"Citation": "Daryabeygi-Khotbehsara R, Golzarand M, Ghaffari MP, Djafarian K. Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: a systematic review and meta-analysis. Complement Ther Med. (2017) 35:6\u201313. 10.1016/j.ctim.2017.08.016", "ArticleIdList": ["10.1016/j.ctim.2017.08.016", "29154069"]}, {"Citation": "Askari G, Rouhani MH, Ghaedi E, Ghavami A, Nouri M, Mohammadi H. Effect of Nigella sativa (black seed) supplementation on glycemic control: a systematic review and meta-analysis of clinical trials. Phytother Res. (2019) 33:1341\u201352. 10.1002/ptr.6337", "ArticleIdList": ["10.1002/ptr.6337", "30873688"]}, {"Citation": "Hallajzadeh J, Milajerdi A, Mobini M, Amirani E, Azizi S, Nikkhah E, et al. . Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: a systematic review and meta-analysis of randomized controlled clinical trials. Phytother Res. (2020) 34:2586\u2013608. 10.1002/ptr.6708", "ArticleIdList": ["10.1002/ptr.6708", "32394508"]}, {"Citation": "Mohtashami A, Entezari MH. Effects of Nigella sativa supplementation on blood parameters and anthropometric indices in adults: a systematic review on clinical trials. J Res Med Sci. (2016) 21:3. 10.4103/1735-1995.175154", "ArticleIdList": ["10.4103/1735-1995.175154", "PMC5122217", "27904549"]}, {"Citation": "Kanter M. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res. (2008) 33:87\u201396. 10.1007/s11064-007-9419-5", "ArticleIdList": ["10.1007/s11064-007-9419-5", "17713854"]}, {"Citation": "Benhaddou-Andaloussi A, Martineau LC, Spoor D, Vuong T, Leduc C, Joly E, et al. . Antidiabetic activity of Nigella sativa. seed extract in cultured pancreatic \u03b2ancreat skeletal muscle cells, and adipocytes. Pharm Biol. (2008) 46:96\u2013104. 10.1080/13880200701734810", "ArticleIdList": ["10.1080/13880200701734810"]}, {"Citation": "Benhaddou-Andaloussi A, Martineau L, Vuong T, Meddah B, Madiraju P, Settaf A, et al. . The in vivo antidiabetic activity of Nigella sativa is mediated through activation of the AMPK pathway and increased muscle Glut4 content. Evid Based Complement Alternat Med. (2011) 2011:538671. 10.1155/2011/538671", "ArticleIdList": ["10.1155/2011/538671", "PMC3092603", "21584245"]}, {"Citation": "Pari L, Sankaranarayanan C. Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin\u2013nicotinamide induced diabetic rats. Life Sci. (2009) 85:830\u20134. 10.1016/j.lfs.2009.10.021", "ArticleIdList": ["10.1016/j.lfs.2009.10.021", "19903489"]}, {"Citation": "Meddah B, Ducroc R, El Abbes Faouzi M, Eto B, Mahraoui L, Benhaddou-Andaloussi A, et al. . Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J Ethnopharmacol. (2009) 121:419\u201324. 10.1016/j.jep.2008.10.040", "ArticleIdList": ["10.1016/j.jep.2008.10.040", "19061948"]}, {"Citation": "Hannan JMA, Ansari P, Haque A, Sanju A, Huzaifa A, Rahman A, et al. . Nigella sativa stimulates insulin secretion from isolated rat islets and inhibits the digestion and absorption of (CH(2)O)(n) in the gut. Biosci Rep. (2019) 39:723. 10.1042/BSR20190723", "ArticleIdList": ["10.1042/BSR20190723", "PMC6706595", "31375555"]}, {"Citation": "Ma C, Yu H, Xiao Y, Wang H. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats. Pharm Biol. (2017) 55:2170\u20137. 10.1080/13880209.2017.1396350", "ArticleIdList": ["10.1080/13880209.2017.1396350", "PMC6130557", "29110587"]}, {"Citation": "O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clinic Proc. (1998) 73:969\u201376. 10.4065/73.10.969", "ArticleIdList": ["10.4065/73.10.969", "9787748"]}, {"Citation": "Oza MJ, Kulkarni YA. Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes. Biomed Pharmacother. (2018) 107:1119\u201327. 10.1016/j.biopha.2018.08.073", "ArticleIdList": ["10.1016/j.biopha.2018.08.073", "30257324"]}, {"Citation": "Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr. (2012) 142:592s\u22129s. 10.3945/jn.111.155259", "ArticleIdList": ["10.3945/jn.111.155259", "22279140"]}, {"Citation": "Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. (2014) 105:141\u201350. 10.1016/j.diabres.2014.04.006", "ArticleIdList": ["10.1016/j.diabres.2014.04.006", "24798950"]}, {"Citation": "Nowotny K, Jung T, H\u00f6hn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. (2015) 5:194\u2013222. 10.3390/biom5010194", "ArticleIdList": ["10.3390/biom5010194", "PMC4384119", "25786107"]}, {"Citation": "Kengne AP, Batty GD, Hamer M, Stamatakis E, Czernichow S. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four UK prospective cohort studies. Diabetes Care. (2012) 35:396\u2013403. 10.2337/dc11-1588", "ArticleIdList": ["10.2337/dc11-1588", "PMC3263864", "22210562"]}, {"Citation": "Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, et al. . Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. (2013) 36:166\u201375. 10.2337/dc12-0702", "ArticleIdList": ["10.2337/dc12-0702", "PMC3526249", "23264288"]}, {"Citation": "Salem M, Kholoussi S, Kholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hellenic Med. (2011) 28:83\u20138."}, {"Citation": "Hadi V, Pahlavani N, Malekahmadi M, Nattagh-Eshtivani E, Navashenaq JG, Hadi S, et al. . Nigella sativa in controlling Type 2 diabetes, cardiovascular, and rheumatoid arthritis diseases: molecular aspects. J Res Med Sci. (2021) 26:20. 10.4103/jrms.JRMS_236_20", "ArticleIdList": ["10.4103/jrms.JRMS_236_20", "PMC8240544", "34221050"]}, {"Citation": "Ardiana M, Pikir BS, Santoso A, Hermawan HO, Al-Farabi MJ. Effect of Nigella sativa supplementation on oxidative stress and antioxidant parameters: a meta-analysis of randomized controlled trials. Sci World J. (2020) 2020:2390706. 10.1155/2020/2390706", "ArticleIdList": ["10.1155/2020/2390706", "PMC7225850", "32454800"]}, {"Citation": "Golay A, Ybarra J. Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab. (2005) 19:649\u201363. 10.1016/j.beem.2005.07.010", "ArticleIdList": ["10.1016/j.beem.2005.07.010", "16311223"]}, {"Citation": "Houcher Z, Boudiaf K, Benboubetra M, Houcher B. Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in alloxan-induced diabetic rats. Pteridines. (2007) 18:8\u201318. 10.1515/pteridines.2007.18.1.8", "ArticleIdList": ["10.1515/pteridines.2007.18.1.8"]}, {"Citation": "Tasawar Z, Siraj Z, Ahmad N, Lashari MH. The effects of Nigella sativa (Kalonji) on lipid profile in patients with stable coronary artery disease in Multan, Pakistan. Pak J Nutr. (2011) 219:173\u201381. 10.3923/pjn.2011.162.167", "ArticleIdList": ["10.3923/pjn.2011.162.167"]}, {"Citation": "Namazi N, Larijani B, Ayati MH, Abdollahi M. The effects of Nigella sativa L. on obesity: a systematic review and meta-analysis. J Ethnopharmacol. (2018) 219:173\u201381. 10.1016/j.jep.2018.03.001", "ArticleIdList": ["10.1016/j.jep.2018.03.001", "29559374"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "24"}, {"Year": "2022", "Month": "7", "Day": "25"}, {"Year": "2022", "Month": "8", "Day": "29", "Hour": "5", "Minute": "16"}, {"Year": "2022", "Month": "8", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36034891", "PMC9403837", "10.3389/fnut.2022.977756"]}}], "PubmedBookArticle": []}